$MRK
Merck & Co., Inc.

2021 Q1 Form 10-Q Financial Statement

#000031015821000009 Filed on May 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $10.63B $12.06B
YoY Change -11.86% 11.47%
Cost Of Revenue $3.199B $3.312B
YoY Change -3.41% 8.52%
Gross Profit $7.428B $8.745B
YoY Change -15.06% 12.64%
Gross Profit Margin 69.9% 72.53%
Selling, General & Admin $2.187B $2.555B
YoY Change -14.4% 5.36%
% of Gross Profit 29.44% 29.22%
Research & Development $2.412B $2.209B
YoY Change 9.19% 14.4%
% of Gross Profit 32.47% 25.26%
Depreciation & Amortization $378.0M $821.0M
YoY Change -53.96% -8.57%
% of Gross Profit 5.09% 9.39%
Operating Expenses $4.599B $4.764B
YoY Change -3.46% 9.37%
Operating Profit $2.829B $3.981B
YoY Change -28.94% 16.81%
Interest Expense $200.0M $212.0M
YoY Change -5.66% 1.44%
% of Operating Profit 7.07% 5.33%
Other Income/Expense, Net $455.0M -$71.00M
YoY Change -740.85% -62.23%
Pretax Income $2.987B $3.838B
YoY Change -22.17% 25.14%
Income Tax $238.0M $619.0M
% Of Pretax Income 7.97% 16.13%
Net Earnings $3.179B $3.219B
YoY Change -1.24% 10.43%
Net Earnings / Revenue 29.91% 26.7%
Basic Earnings Per Share $1.26 $1.27
Diluted Earnings Per Share $1.25 $1.26
COMMON SHARES
Basic Shares Outstanding 2.531B shares 2.533B shares
Diluted Shares Outstanding 2.541B shares 2.547B shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.981B $7.432B
YoY Change -6.07% -15.23%
Cash & Equivalents $6.981B $7.425B
Short-Term Investments $7.000M
Other Short-Term Assets $5.291B $4.714B
YoY Change 12.24% 45.81%
Inventory $6.402B $5.846B
Prepaid Expenses
Receivables $8.235B $8.182B
Other Receivables $0.00 $0.00
Total Short-Term Assets $26.91B $26.17B
YoY Change 2.81% 3.25%
LONG-TERM ASSETS
Property, Plant & Equipment $18.30B $15.27B
YoY Change 19.82% 13.05%
Goodwill $20.21B $19.77B
YoY Change 2.25% 8.79%
Intangibles $14.40B $16.10B
YoY Change -10.53% 46.34%
Long-Term Investments $544.0M $555.0M
YoY Change -1.98% -90.13%
Other Assets $10.49B $7.052B
YoY Change 48.7% -19.01%
Total Long-Term Assets $63.94B $58.74B
YoY Change 8.85% 3.05%
TOTAL ASSETS
Total Short-Term Assets $26.91B $26.17B
Total Long-Term Assets $63.94B $58.74B
Total Assets $90.85B $84.91B
YoY Change 6.99% 3.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.034B $3.572B
YoY Change 12.93% 18.36%
Accrued Expenses $11.91B $10.93B
YoY Change 8.96% 10.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.251B $6.361B
YoY Change 13.99% 100.35%
Total Short-Term Liabilities $26.36B $23.48B
YoY Change 12.26% 26.64%
LONG-TERM LIABILITIES
Long-Term Debt $24.00B $21.64B
YoY Change 10.93% -4.77%
Other Long-Term Liabilities $12.24B $11.55B
YoY Change 5.98% -0.3%
Total Long-Term Liabilities $36.24B $33.19B
YoY Change 9.21% -3.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.36B $23.48B
Total Long-Term Liabilities $36.24B $33.19B
Total Liabilities $62.60B $56.67B
YoY Change 10.47% 7.23%
SHAREHOLDERS EQUITY
Retained Earnings $48.89B $48.27B
YoY Change 1.28% 9.55%
Common Stock $41.40B $41.49B
YoY Change -0.2% 2.29%
Preferred Stock
YoY Change
Treasury Stock (at cost) $56.72B $57.16B
YoY Change -0.77% 10.49%
Treasury Stock Shares 1.046B shares 1.053B shares
Shareholders Equity $26.95B $26.21B
YoY Change
Total Liabilities & Shareholders Equity $90.85B $84.91B
YoY Change 6.99% 3.11%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $3.179B $3.219B
YoY Change -1.24% 10.43%
Depreciation, Depletion And Amortization $378.0M $821.0M
YoY Change -53.96% -8.57%
Cash From Operating Activities $1.791B $707.0M
YoY Change 153.32% -47.08%
INVESTING ACTIVITIES
Capital Expenditures -$1.134B -$986.0M
YoY Change 15.01% 65.71%
Acquisitions $14.00M $0.00
YoY Change
Other Investing Activities -$11.00M -$136.0M
YoY Change -91.91% 257.89%
Cash From Investing Activities -$738.0M -$1.628B
YoY Change -54.67% -542.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $1.281B
YoY Change -100.0% 17.52%
Debt Paid & Issued, Net $1.153B $1.951B
YoY Change -40.9%
Cash From Financing Activities -$2.098B -$1.490B
YoY Change 40.81% -7.68%
NET CHANGE
Cash From Operating Activities $1.791B $707.0M
Cash From Investing Activities -$738.0M -$1.628B
Cash From Financing Activities -$2.098B -$1.490B
Net Change In Cash -$1.142B -$2.474B
YoY Change -53.84% -2349.09%
FREE CASH FLOW
Cash From Operating Activities $1.791B $707.0M
Capital Expenditures -$1.134B -$986.0M
Free Cash Flow $2.925B $1.693B
YoY Change 72.77% -12.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000310158
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
1-6571
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Merck & Co., Inc.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-1918501
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2000 Galloping Hill Road
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Kenilworth
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07033
CY2021Q1 dei City Area Code
CityAreaCode
(908)
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
740-4000
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2532058364 shares
CY2021Q1 us-gaap Revenues
Revenues
12080000000 USD
CY2020Q1 us-gaap Revenues
Revenues
12057000000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3670000000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3312000000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2633000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2555000000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2465000000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2209000000 USD
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
298000000 USD
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
72000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
448000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-71000000 USD
CY2021Q1 mrk Costs Expenses And Other
CostsExpensesAndOther
8618000000 USD
CY2020Q1 mrk Costs Expenses And Other
CostsExpensesAndOther
8219000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3462000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3838000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
276000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
619000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
3186000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
3219000000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7000000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3179000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3219000000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.25
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3179000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3219000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
230000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
104000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-18000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-81000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-60000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-299000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-344000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-198000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3191000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3021000000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6981000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8062000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
78000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
85000000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8235000000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7851000000 USD
CY2021Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
2175000000 USD
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2197000000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
6402000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
6310000000 USD
CY2021Q1 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
5291000000 USD
CY2020Q4 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
5541000000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
26909000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
27764000000 USD
CY2021Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
544000000 USD
CY2020Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
785000000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18732000000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18982000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18295000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17986000000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
20212000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
20238000000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14401000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14604000000 USD
CY2021Q1 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
10486000000 USD
CY2020Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
10211000000 USD
CY2021Q1 us-gaap Assets
Assets
90847000000 USD
CY2020Q4 us-gaap Assets
Assets
91588000000 USD
CY2021Q1 us-gaap Debt Current
DebtCurrent
7251000000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
6431000000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4034000000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4594000000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11911000000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13053000000 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1490000000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1575000000 USD
CY2021Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
1675000000 USD
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1674000000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
26361000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27327000000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
24002000000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25360000000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1204000000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1015000000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12241000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12482000000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6500000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6500000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3577103522 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3577103522 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
1788000000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1788000000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39613000000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39588000000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48888000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
47362000000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6622000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6634000000 USD
CY2021Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
83667000000 USD
CY2020Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
82104000000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1045799775 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1046877695 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
56722000000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
56787000000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
26945000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
25317000000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
94000000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
87000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27039000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25404000000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90847000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
91588000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
3186000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
3219000000 USD
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
534000000 USD
CY2020Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
410000000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
396000000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
411000000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10000000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
82000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
120000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
108000000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
331000000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-143000000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
2104000000 USD
CY2020Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
3666000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1791000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
707000000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1134000000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
986000000 USD
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1000000 USD
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
49000000 USD
CY2021Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
386000000 USD
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1816000000 USD
CY2021Q1 us-gaap Payments To Acquire Business Three Net Of Cash Acquired
PaymentsToAcquireBusinessThreeNetOfCashAcquired
0 USD
CY2020Q1 us-gaap Payments To Acquire Business Three Net Of Cash Acquired
PaymentsToAcquireBusinessThreeNetOfCashAcquired
2545000000 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14000000 USD
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-25000000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-136000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-738000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1628000000 USD
CY2021Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
788000000 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
3583000000 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1153000000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1951000000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1281000000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1645000000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1551000000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26000000 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-97000000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-316000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2098000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1490000000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-97000000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-63000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1142000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2474000000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
103000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8165000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9934000000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
42000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7023000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7460000000 USD
CY2021Q1 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
3000000000.0 USD
CY2021Q1 mrk Estimate Of Cumulative Pre Tax Costs That Will Result In Cash Outlays
EstimateOfCumulativePreTaxCostsThatWillResultInCashOutlays
0.70
CY2021Q1 mrk Estimate Of Cumulative Pre Tax Costs That Will Be Noncash
EstimateOfCumulativePreTaxCostsThatWillBeNoncash
0.30
CY2021Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
335000000 USD
CY2020Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
168000000 USD
CY2021Q1 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
2100000000 USD
CY2021Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
335000000 USD
CY2020Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
168000000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
603000000 USD
CY2021Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
335000000 USD
CY2021Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
227000000 USD
CY2021Q1 mrk Restructuring Reserve Increase Decrease Noncash Activity
RestructuringReserveIncreaseDecreaseNoncashActivity
2000000 USD
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
713000000 USD
CY2021Q1 us-gaap Derivative Assets
DerivativeAssets
415000000 USD
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
281000000 USD
CY2021Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
33995000000 USD
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
182000000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
525000000 USD
CY2020Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
32784000000 USD
CY2021Q1 us-gaap Derivative Assets
DerivativeAssets
415000000 USD
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
281000000 USD
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
182000000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
525000000 USD
CY2021Q1 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
213000000 USD
CY2021Q1 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
213000000 USD
CY2020Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
156000000 USD
CY2020Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
156000000 USD
CY2021Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
19000000 USD
CY2021Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
36000000 USD
CY2021Q1 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
183000000 USD
CY2021Q1 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
68000000 USD
CY2020Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
26000000 USD
CY2020Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
333000000 USD
CY2021Q1 us-gaap Revenues
Revenues
12080000000 USD
CY2020Q1 us-gaap Revenues
Revenues
12057000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
448000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-71000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-198000000 USD
CY2021Q1 us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
-72000000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
87000000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87000000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
89000000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
89000000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1596000000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1787000000 USD
CY2021Q1 mrk Debt Securitiesand Equity Securities Fvni
DebtSecuritiesandEquitySecuritiesFVNI
1683000000 USD
CY2020Q4 mrk Debt Securitiesand Equity Securities Fvni
DebtSecuritiesandEquitySecuritiesFVNI
1876000000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-181000000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4000000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
651000000 USD
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
450000000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
33000000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
202000000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
11000000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
841000000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
767000000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-13000000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
33000000 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
106000000 USD
CY2021Q1 mrk Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Other
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOther
12000000 USD
CY2020Q1 mrk Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Other
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOther
0 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
816000000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
694000000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
285000000 USD
CY2021Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
33500000000 USD
CY2021Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
31300000000 USD
CY2020Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
36000000000.0 USD
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
31800000000 USD
CY2021Q1 us-gaap Accounts Receivable Sale
AccountsReceivableSale
1800000000 USD
CY2020Q4 us-gaap Accounts Receivable Sale
AccountsReceivableSale
2300000000 USD
CY2021Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
19000000 USD
CY2021Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
28000000 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
36000000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2015000000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1963000000 USD
CY2021Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
6385000000 USD
CY2020Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
6420000000 USD
CY2021Q1 us-gaap Other Inventory Supplies
OtherInventorySupplies
205000000 USD
CY2020Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
206000000 USD
CY2021Q1 us-gaap Inventory Gross
InventoryGross
8605000000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
8589000000 USD
CY2020Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
82000000 USD
CY2021Q1 mrk Inventory Net And Inventory Noncurrent
InventoryNetAndInventoryNoncurrent
8577000000 USD
CY2020Q4 mrk Inventory Net And Inventory Noncurrent
InventoryNetAndInventoryNoncurrent
8507000000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
6402000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
6310000000 USD
CY2021Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
2175000000 USD
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2197000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26001000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3219000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-198000000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.61
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1549000000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1281000000 USD
CY2020Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-107000000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26300000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25404000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3179000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.65
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1653000000 USD
CY2021Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-90000000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27039000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
120000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
108000000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
17000000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
15000000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
103000000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
93000000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1200000000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
11000000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
25000000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
200000000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
212000000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-47000000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-54000000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
574000000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
52000000 USD
CY2021Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-89000000 USD
CY2020Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-90000000 USD
CY2021Q1 mrk Other Nonoperating Income Expense Other
OtherNonoperatingIncomeExpenseOther
21000000 USD
CY2020Q1 mrk Other Nonoperating Income Expense Other
OtherNonoperatingIncomeExpenseOther
28000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
448000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-71000000 USD
CY2021Q1 us-gaap Interest Paid
InterestPaid
217000000 USD
CY2020Q1 us-gaap Interest Paid
InterestPaid
250000000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.080
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.161
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3179000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3219000000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2531000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2533000000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10000000 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14000000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2541000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2547000000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.25
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14000000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
CY2020Q1 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
-152000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Tax
OtherComprehensiveIncomeLossBeforeReclassificationsTax
43000000 USD
CY2020Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-195000000 USD
CY2020Q1 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-1000000 USD
CY2020Q1 us-gaap Reclassification From Aoci Current Period Tax
ReclassificationFromAociCurrentPeriodTax
-4000000 USD
CY2020Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
3000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-198000000 USD
CY2021Q1 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
-35000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Tax
OtherComprehensiveIncomeLossBeforeReclassificationsTax
127000000 USD
CY2021Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-162000000 USD
CY2021Q1 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-198000000 USD
CY2021Q1 us-gaap Reclassification From Aoci Current Period Tax
ReclassificationFromAociCurrentPeriodTax
-24000000 USD
CY2021Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-174000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12000000 USD
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2021Q1 us-gaap Revenues
Revenues
12080000000 USD
CY2020Q1 us-gaap Revenues
Revenues
12057000000 USD
CY2021Q1 mrk Sales Discounts
SalesDiscounts
3300000000 USD
CY2020Q1 mrk Sales Discounts
SalesDiscounts
3200000000 USD
CY2021Q1 us-gaap Revenues
Revenues
12080000000 USD
CY2020Q1 us-gaap Revenues
Revenues
12057000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3462000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3838000000 USD

Files In Submission

Name View Source Status
0000310158-21-000009-index-headers.html Edgar Link pending
0000310158-21-000009-index.html Edgar Link pending
0000310158-21-000009.txt Edgar Link pending
0000310158-21-000009-xbrl.zip Edgar Link pending
exhibit311-rule13ax14a15dx.htm Edgar Link pending
exhibit312-rule13ax14a15dx.htm Edgar Link pending
exhibit321-section1350cert.htm Edgar Link pending
exhibit322-section1350cert.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrk-20210331.htm Edgar Link pending
mrk-20210331.xsd Edgar Link pending
mrk-20210331_cal.xml Edgar Link unprocessable
mrk-20210331_def.xml Edgar Link unprocessable
mrk-20210331_htm.xml Edgar Link completed
mrk-20210331_lab.xml Edgar Link unprocessable
mrk-20210331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending